Concepedia

Carlos Zepeda‐Velázquez

CZ

Statistics

Publications

13

Citations

572

H-Index

12

Active since

2013

Affiliations

McMaster University(Current)

Structural Genomics Consortium

Ontario Institute for Cancer Research

University of Toronto

Johns Hopkins University

Carlos Zepeda‐Velázquez is an author at McMaster University specializing in medicinal chemistry, drug discovery, and pharmacology.

ORCID

Publications per year

2013–2021

13

Publications

13

A chemical biology toolbox to study protein methyltransferases and epigenetic signaling

Sebastian Scheer, Suzanne Ackloo, Tiago da Silva Medina et al. · Nature Communications · 2018 · 149 citations · Full text

, , +13

Structure-Based Optimization of a Small Molecule Antagonist of the Interaction Between WD Repeat-Containing Protein 5 (WDR5) and Mixed-Lineage Leukemia 1 (MLL1)

Matthäus Getlik, David Smil, Carlos Zepeda‐Velázquez et al. · Journal of Medicinal Chemistry · 2016 · 90 citations · Full text

, , +14

Enantioselective Organocatalytic Michael/Aldol Sequence: Anticancer Natural Product (+)‐<i>trans</i>‐Dihydrolycoricidine

James McNulty, Carlos Zepeda‐Velázquez · Angewandte Chemie International Edition · 2014 · 65 citations

, , +11

Discovery of Small-Molecule Antagonists of the PWWP Domain of NSD2

Renato Ferreira de Freitas, Yanli Liu, Magdalena M. Szewczyk et al. · Journal of Medicinal Chemistry · 2021 · 65 citations · Full text

, , +17

iPSC Neuronal Assay Identifies Amaryllidaceae Pharmacophore with Multiple Effects against Herpesvirus Infections

James McNulty, Leonardo D’Aiuto, Yun Zhi et al. · ACS Medicinal Chemistry Letters · 2015 · 31 citations

, , +17

1–5 of 13